Arthur Cox advises Alkermes plc on the deal. Alkermes plc completed the separation of its oncology business into Mural Oncology plc, a new, independent, publicly traded company...
Alkermes plc’s Separation of its Oncology Business
Alkermes’ Successful Proxy Contest Against Sarissa Capital
Sidley represented Alkermes plc in its successful proxy contest. Willkie represented Sarissa Capital. Alkermes plc (Nasdaq: ALKS) announced that, at the company’s 2023 Annual General Meeting...